INTRODUCTION
Rhodococcus equi is a well-recognized bacterial pathogen in veterinary medicine. First isolated from Swedish foals by Magnusson in 1923 (96) , it causes an important chronic granulomatous pneumonia and lung abscesses in foals aged under 4 months and is a common isolate from cervical lymph nodes in swine. Although rare, infection also occurs in a wide variety of other mammals, often following immunosuppression of various causes. Infections in these unusual hosts commonly include granulomatous pneumonia which develops into lung abscesses, lymphadenitis (often of the mesenteric, bronchial, or cervical lymph nodes), wound infections, and abscesses in various parts of the body. Before 1983, only 12 cases had been reported in humans (176) . At least 20 additional cases have been described since then, the majority of which have been in patients with AIDS. The increased number of human cases reported recently is partly the result of the spread of AIDS but may also reflect the increasing awareness by medical laboratories of this opportunistic pathogen and their improved ability to identify it rather than to dismiss it as a contaminating "micrococcus" or "diphtheroid." Our current understanding of R. equi comes primarily from equine research, though it can be applied in part to the organism as a human opportunist pathogen. Other reviews are available (6, 42, 43) . The present review emphasizes the questions that a medical microbiologist might ask when faced with a bacterial isolate that needs confirming as R. equi, as well as the questions that physicians might ask when treating a patient with confirmed R. equi infection.
TAXONOMIC STATUS
Magnusson in 1923 proposed the name Corynebacterium equi for isolates from foals with pyogranulomatous pneumonia (96) . The subsequent confusing taxonomic history of the organism, which is currently described as both Corynebacterium and Rhodococcus in the Approved List of Bacterial Names (153) , has been generally resolved with improvements in the methods used to classify the nocardioform actinomycetes (62, 63) . The genus Rhodococcus ("redpigmented coccus") belongs to the phylogenetic group described as nocardioform actinomycetes, which contains the genera Caseobacter, Corynebacterium, Mycobacterium, Nocardia, Rhodococcus, and the "aurantiaca" taxon (61, 62) , the last of which has recently been proposed as the genus Tsukamurella (33) . These genera are gram-positive, aerobic, catalase-positive bacteria which, in part because of their diverse microscopic and macroscopic morphology, are best characterized by biochemical criteria (22, (61) (62) (63) (64) .
Within the nocardioform actinomycetes, the genus Rhodococcus is characterized by rod-to-coccus morphologic variation during the growth cycle, by the presence of diphosphatidylglycerol, phosphatidylethanolamine, and phosphatidylinositol mannosides; mycolic acids of carbon length 34 to 64 with up to four double bonds; dihydrogenated menaquinones with either eight or nine isoprene units as the major isoprenalog; large amounts of straight-chain, unsaturated fatty acids; and tuberculostearic acid. The genus Rhodococcus (61) is heterogeneous and can be divided into two groups. Those species originally classified in the genus Gordona (R. bronchialis, R. rubropectinus, and R. terrae) have 48-to 66-carbon-atom mycolic acids and nine isoprene dihydrogenated menaquinones and produce mycobactins (61) . All other species produce 34-to 52-carbon mycolic acids with up to two double bonds and eight isoprene dihydrogenated menaquinones, but not mycobactins (61, 67, 173) . Recently, Stackebrandt and others (157) have reinstated the genus Gordona for the three species originally in this genus while keeping the genus Rhodococcus for the second group. This redefined genus Rhodococcus contains 12 recognized species (3, 63, 157, 195) (175) . Little is known about the pathogenicity for animals or humans of rhodococci other than R. equi.
EPIDEMIOLOGICAL ASPECTS OF INFECTION
R. equi is largely a soil organism with simple growth requirements, which appear to be met perfectly by herbivore manure and summer temperatures in temperate climates (126) . The organism is widespread in grazing animals and their environment. Organisms have been isolated from the feces or intestines of a high proportion of herbivores or omnivores, including cattle, deer, goats, horses, pigs, and sheep (23, 184, 188) ; and from the manure of a high proportion of wild birds but uncommonly in the manure of chickens (23) . By contrast, the organism appears rare in the feces of dogs and was not isolated from cats (23) , and only two isolates have been made from 521 human fecal samples (115) .
As an obligate aerobe (61), R. equi is unlikely to multiply in the anaerobic environment of the large bowel of herbivores (7, 119, 188) and therefore is unlikely to be normal flora in the intestine. It might, however, multiply in the more aerobic environment of the small bowel. Although there is no direct evidence that it multiplies in the intestine of adult herbivores, the organism multiplies in the first 8 weeks of life within the foal intestine (167) . This multiplication, however, ceases by 12 weeks of age, probably when an adult type of intestinal flora has developed (78, 167) . The widespread presence of the organism in adult herbivore feces seems largely to reflect acquisition from feed contaminated with R. equi (7, 169) . The widespread presence of R. equi antibody in the horse population (discussed below) suggests that antigenic stimulation by organisms either transiently passing through or perhaps growing in the intestine is a common event. The highest numbers of R. equi are found in the surface soil on infected-horse farms (166) , which would be expected of aerobic organisms dependent for growth on simple nutrients derived from herbivore manure. The multiplication of R. equi in herbivore manure can be striking. For example, Barton and Hughes reported that R. equi multiplied 10,000-fold in horse manure kept under Australian spring temperatures (daytime temperatures fluctuating from 15 to 37°C; nighttime, from 5 to 9°C) for 14 days (7) .
The multiplication of R. equi in soil depends on environmental temperatures, the presence of volatile fatty acids from herbivore manure, and on soil pH (78, 160) . The organism does not multiply at 10°C or below (78, 160, 166) . Differences in environmental conditions between years may explain the annual variation in number of cases of R. equi diagnosed in foals (144) . In one study, the number of R. equi isolated from the air on horse farms rose with environmental temperatures and was highest on dry and windy days (160) . Aerosol infection via dust is thought to be the major route of foal infection (155) .
R. equi infection in horses occurs endemically on some horse farms and sporadically on others and is not recognized on most (144) . Despite this difference in epidemiology, most horses develop immunological evidence of infection (71, 131, 162) , although horses on farms where disease is endemic are most likely to have high levels of antibody (151) . Extrapolating from these epidemiological characteristics as well as from studies of macrophage-R. equi interactions in vitro (69) , it seems that young foals can overcome infection with low numbers of R. equi; heavy or continuous exposure predisposes them to disease, particularly in the absence of antibody or fully competent cell-mediated immune mechanisms. On horse farms, there is progressive increase of environmental contamination with R. equi (133) , related to the length of use of the farm for horses (presumably a reflection of concentration of horses and manure disposal practices, summer temperatures, soil type, and whether or not the farm is used to breed foals). Clinical isolates from foals are usually more virulent for mice than environmental isolates (16) .
The suggestion that pneumonia in foals results from migration of R. equi-infected helminth larvae through the lungs, and therefore that helminth control may prevent the disease (5), has not been confirmed. (144, 199) , or by growth of the organism in transtracheal cultures of apparently healthy foals (4) . Foals are affected up to 6 months of age; most clinical cases occur by 2 months of age (4, 96, 97, 137, 199) . In one large study of 89 foals that died of pneumonia and/or enterocolitis, duration of illness was <1 week in 26%, between 1 and 3 weeks in 25%, and >3 weeks in 49%. The disease occurs in the summer months, which usually coincides with the presence of foals of peak age susceptibility. While not well documented, infection may be predisposed by viral respiratory disease in foals (144) .
Early signs of the usual, chronic progressive form of the disease associated with multiple, massive lung abscesses are fever (up to 41°C), increased respiratory rate with bronchovesicular sounds over large airways and wheezing over small airways, cough and, sometimes, bilateral nasal discharge and depression (4, 5, 49) . As the lung abscesses develop, foals show progressive increases in respiratory rate and depth, and movement becomes increasingly distressful. The chronic disease may progress inexorably in untreated animals until eventually they die of asphyxiation (43, 137, 199) . In foals with the chronic form of the disease, severe diarrhea may develop as a result of colonic mucosal invasion by R. equi (31, 144, 199) . Rarely, colitis without lung involvement may occur (144) . There are no pathognomonic signs of R. equi pneumonia in foals, although a chronic, active, nonseptic synovitis characterized by joint distension has been described in about one-third of affected animals (159) . Foals with pneumonic disease show elevated total leukocyte counts, predominantly neutrophils. Plasma fibrinogen values are elevated, to levels correlating well with the degree of lung damage (49) . Occasionally, the disease develops very acutely (144) , characterized by sudden onset of respiratory disease and death within 24 to 48 h. In some cases this is associated with a sudden and overwhelming exposure of the lung to many organisms (144) .
Radiographically, in the acute stages of infection, foals with R. equi pneumonia tend to have a prominent interstitial pattern of infiltrates which progresses to a consolidated, alveolar pattern with nodular and cavitary lesions. Particularly in severely ill foals, these lesions are accompanied by lymphadenopathy (49) . Serial thoracic radiographs are used to monitor the progression of the disease (4).
Ulcerative lymphangitis caused by R. equi has occasionally been reported to develop on foal legs (5, 48, 122, 154) . This condition appears to be a wound superinfection, the origin of which may be migrating Strongyloides westeri larvae in some cases (38, 39) . Occasionally, R. equi may disseminate from lung abscesses to intervertebral or other joints (such as those of the long bones) or to other body sites, including the eye, to cause localized infections (97, 137, 199) . Pleurisy and peritonitis are uncommon presentations (5) .
Clinical manifestations in adults. Disease due to R. equi is rare in adult horses. It manifests as a sporadically occurring illness similar to that observed in foals, involving primarily lungs or colon and related lymph nodes, or rarely as wound infection (43, 59, 142, 150, 199 (83) . The eventual degeneration of the macrophages coincides with the development of focal lytic lesions in, and destruction of, the lung parenchyma. Caseous necrosis is the dominant lesion in advanced lung disease in some experimentally and naturally infected foals (83) , but in most naturally infected foals advanced lesions are suppurative rather than caseous (199) .
In the intestine, a pyogranulomatous process similar to that described in the lungs begins in the Peyer's patches, which are destroyed with formation of ulcerated areas. As in the lung, infection spreads to involve local lymph nodes which may become considerably enlarged (84) . Fixed macrophages in the body appear to destroy R. equi better than alveolar macrophages since, despite the bacteremia that may occur during infection, lesions in the liver and spleen are rare (190) . Alveolar macrophages are relatively inefficient compared with macrophages from other sites in providing the accessory function required for initiation of the immune response (104).
Humans
In immunosuppressed patients, R. equi infections occur mainly in the lungs. Of 32 cases reported (Table 1) , 88% were associated with immunosuppression following the development of AIDS, treatment for hemolymphatic tumors, or the prevention of rejection following renal transplantation. Two cases of panophthalmitis followed penetrating eye injuries. In two cases (cervical lymphadenitis in a child, hepatic fistula in an adult) infection appeared to follow dissemination from the mouth or intestine (85, 172) .
Pneumonia was the main presenting problem in two-thirds (21 of 32) of patients. Exceptions were two cases of penetrating eye wounds (41, 73) , one AIDS patient with an inflammatory mass in the pelvis (51), one AIDS patient with bloody diarrhea and cachexia (51), one patient with pleural effusion (91), one patient with osteomyelitis (which followed a pneumonic episode) (121), one renal transplant patient with a paraspinal abscess (85) , one AIDS patient with a psoas abscess (51), one asymptomatic renal transplant patient with a lung abscess recognized on radiography (176), one AIDS patient with an "inflammatory pseudotumor" in the lung (13) , and a child with cervical lymphadenitis (172) .
In the usual pneumonic presentation of infection, patients gradually developed fever of several days to several weeks in duration, with malaise, dyspnea, and nonproductive cough; in some cases hemoptysis is described. Patients often complain of chest pain. Radiographic abnormalities in the early stages are typically infiltrative, with opaque lesions commonly localized to one upper lung lobe. Lesions may vary in size from 2-cm nodules to those involving a large part of the affected lobe. If untreated or treated inappropriately, lesions persist, often enlarge, and, typically in 2 to 4 weeks, develop into cavities characterized by the presence of an air-fluid line within the lesion. In a few cases, pleural effusions have been the prominent lesions (91, 176) .
The changes commonly described are also characteristic of those associated with tubercular or fungal infections which should be differentiated by using appropriate skin or microbiologic tests, although the impaired immune response in AIDS patients reduces the value of immunologic tests (41) . The fluorochromes used to detect mycobacterial organisms in clinical specimens may give positive results with R. equi, so that infection may be misdiagnosed in the early stages of the disease (51, 90) . R. equi is one of the causes of cavitatory pulmonary disease in AIDS patients and may be regarded as a possible indicator of AIDS (66) . Dissemination from focal lung sites to brain, skin, paraspinal tissue, and bone has occasionally been described (12, 60, 85, 121, 176) .
No age predisposition is apparent, but 78% of patients were male, largely because of the greater association of AIDS with males. A possible animal source of infection was recorded in 12 of 32 patients but only one of these was an AIDS patient, a farm worker with exposure to horses and other animals (178) . Since the major route of R. equi infection is by soil contaminated with manure of herbivorous animal origin, it is not surprising that some patients were livestock farmers (74, 95) , worked with animal manure in a garden (12) , or cleaned out dusty cattle, sheep, and pig pens in stockyards (60) . Nevertheless, most patients have had no such history of exposure that might account for their infection, although bird feces might be one unrecognized source of infection (23) .
Natural Infections in Other Species
R. equi has been isolated from many species other than humans and horses (Table 2) , but with the marked exception of pigs which develop submaxillary lymphadenitis, reports of the isolation from other species are uncommon. Lesions are generally typical of those described in horses and humans. Table 2 illustrates the predominance of disease in herbivores and the tendency for the organism to be isolated from lungs, granulomatous lymph nodes, abscesses, or wound infections. This spectrum of disease is similar to that observed in horses and in humans. Miscellaneous older reports record the isolation of R. equi from aborted fetuses and from animals with mastitis and metritis (18, 19, 35, 138) . The organism has been isolated from ulcerative lymphangitis in cattle (120), apparently following skin wounds made by thorns. In goats the organism may have a tendency to cause liver abscesses, possibly following penetration from the intestinal tract.
In cattle, as in swine, the organism may be isolated from granulomas in lymph nodes, usually respiratory tract nodes (105) . In both species, the lesions from which R. equi have been isolated strikingly resemble those of tuberculosis and have therefore generated considerable interest among veterinarians. Although there are many reports of the isolation of R. equi from the submaxillary lymph nodes of pigs with "tuberculous" lesions (7, 34, 43, 50, 86, 183) , the organism may also be recovered from a similar proportion of normal submaxillary lymph nodes in healthy pigs (34, 50, 86, 168) . For example, Karlson and co-workers (86) isolated R. equi from 22.4% of 89 lymph nodes from tuberculous swine but also from 24% of 25 lymph nodes from healthy pigs. They and others were unable to reproduce submaxillary lymphadenitis in swine by feeding pigs cultures of R. equi (34, 86) . The causative role of R. equi in granulomatous lymphadenitis in swine thus remains unproven, though possible, based on the type of inflammatory changes and the similarity to R. equi lymphadenitis in other species. In some cases the tuberculous lesions observed can be explained by the concurrent presence of various Mycobacterium species (50, 168) . Experimental pneumonic infection mimicking that seen in natural animal or human infection has not been consistently induced in any animal other than the foal. Intranasal or aerosol administration of cultures to the pig and mouse resulted in a subacute, macrophage-rich, interstitial pneumonia which resolved, rather than progressing to the pulmonary abscess stage typical of natural infection (16, 196) .
The normal mouse lung can progressively (but remarkably slowly) clear a heavy inoculum of R. equi (112) . Studies of the early events that occur in mice infected intrabronchially with defined bacterial doses demonstrated clearance of a proportion of bacteria within the first 24 h by nonspecific, largely neutrophil, phagocytes. In addition, a number of organisms survive, apparently within macrophages. Successful defense against this surviving population appeared to require specific cell-mediated immunity (17) . Mice challenged intranasally with R. equi following cyclophosphamide administration often developed fatal infection in contrast to untreated mice, suggesting the importance of functional cellular immunity in protection against infection (112) .
Extensive studies of the susceptibility of mice to experimental Nocardia asteroides infection are relevant to understanding immunity to R. equi, a closely related organism. The susceptibility and tissue response of mice to experimental N. asteroides infection depend on the strain of mouse used, the most susceptible mice having genetic defects affecting T-lymphocyte function (9) . For example, athymic nude (Nu/Nu) mice were protected from the lethal effects of intranasally administered N. asteroides organisms by adoptive transfer of T lymphocytes from preimmunized heterozygous mice (9) . Protection appears to be related in part to macrophage activation but also to a direct cytotoxic effect of T lymphocytes against the organisms (9). Alveolar macrophages from immunized normal (BALB/c) mice were least effective in killing N. asteroides when compared with macrophages isolated from liver, the peritoneal cavity, and the spleen (9) . In studies of mice infected by R. equi by the intravenous, intranasal, or intratracheal route normal mice without genetically defined defects in immune function were used (16, 116, 165) .
Intratracheal inoculation of pigs or guinea pigs resulted in suppurative pulmonary lesions similar to those of the natural disease in foals, but in guinea pigs abscesses did not develop and lesions resolved within a relatively short time (79, 171, 196) . The experimental infection in swine has been less well described (171) .
VIRULENCE AND PATHOGENIC MECHANISMS Susceptibility of the young foal to R. equi pneumonia remains largely unexplained but must relate in part to a combination of factors, including heavy challenge by the respiratory route coinciding with declining maternally derived antibody and absence of fully competent cellular immune mechanisms. Variation in virulence of R. equi isolates has been identified with experimentally infected mice and foals. The type strain isolated by Magnusson (ATCC 6939, NCTC 1621) does not cause pneumonia in foals (100, 163) and is avirulent for mice (116, 165) . Lethality of strains for mice infected intravenously was related to the ability of organisms to resist both clearance from the liver and spleen and phagocytosis and intracellular killing by mouse macrophages (116, 165) . Based on data from experimental infections, clinical isolates are more pathogenic than environmental isolates (16, 52) . The basis of the variation in virulence has not been determined. Differences in mouse virulence in Nocardia spp. have been attributed to certain mycolic acids (10) . Two distinct mycolic acid fractionation patterns have been described for a small number of R. equi isolates, including the avirulent type strain (22) .
Among possible candidates as virulence factors are capsular polysaccharide, which might inhibit phagocytosis of the organism, and cholesterol oxidase and phospholipase C exoenzymes ("equi factors"). Cholesterol oxidase is a prominent product of R. equi (53, 93) . The combined action of the equi factors may confer membranolytic activity on R.
equi (11, 93) , but their role in virulence needs to be defined.
Cholesterol oxidase is produced in different amounts by different strains, but whether this correlates with virulence is unknown (2). Mycolic acid-containing glycolipids of R. equi are likely to promote granuloma formation as do those of other rhodococci, but their role has not been investigated (149) .
The ability of R. equi to persist in and eventually to destroy macrophages is the basis of its pathogenicity. The pathological change elicited by R. equi is similar to that of some other parasites within the group CorynebacteriumMycobacterium-Nocardia, with which it shares lipid-rich cell wall components (61, 106) . Foal alveolar macrophages cultured in vitro rapidly ingested opsonized R. equi, but 75% of ingested organisms remained viable after 4 h of incubation (198) . Electron microscopic examination of the behavior of R. equi in cultured foal and adult horse macrophages showed that organisms evaded killing by preventing phagosomelysosome fusion, thus multiplying in and eventually killing the phagocytes (69, 197) . In addition, nonspecific degranulation of lysosomes in R. equi-infected macrophages has been suggested to be the major survival and pathogenic mechanism of R. equi (69) . Such degranulation in vivo would contribute to the tissue destruction and neutrophil influx that is characteristic of R. equi lung lesions. Opsonization with specific antibody enhanced ingestion, phagosome-lysosome fusion, and killing of R. equi by cultured macrophages (69) .
In vitro, studies of R. equi killing by isolated horse neutrophils have shown excellent bactericidal activity of opsonized organisms and no age-related changes in bactericidal activity (70, 99, 191) . Foal neutrophils were most efficient in ingesting and killing cells when opsonized with specific antibody (69) . One study, however, identified a moderate proportion of neonatal foals whose neutrophil bactericidal activity increased with age (103) . A heat-stable surface component of R. equi, possibly a capsular polysaccharide, has been identified and shown to inhibit the oxygendependent cytotoxic mechanisms of adult horse neutrophils against Staphylococcus aureus (44) . Although this inhibition does not appear to be sufficient to impair overall bactericidal activity of equine neutrophils against opsonized R. equi in vitro (70, 99, 191) , this impairment may be significant in vivo, perhaps in the absence of specific antibody. In contrast to some other Rhodococcus species (67), R. equi does not produce the siderophore mycobactin under iron-limiting growth conditions.
IMMUNITY TO INFECTION
With the exception of the young foal, disease in other species is rare unless, as in most human patients, the host is immunosuppressed. The basis of immunity in horses, particularly that relating to cell-mediated immune mechanisms, is largely unknown. Current understanding of immunity of horses to R. equi has recently been reviewed (187) .
Humoral Immunity in Horses
Early studies of naturally or experimentally infected foals showed a generally inconsistent or low level of antibody detectable by agglutination, passive hemagglutination, complement fixation, or precipitation (20, 26, 97, 117, 129, 137, 180) . The conclusion from these early studies was that there is a negligible humoral response to infection and that immunity is primarily based on cell-mediated mechanisms (20, 129, 131) . The later development of more sensitive detection methods based on enzyme-linked immunosorbent assay (ELISA) with various antigens, indirect immunofluorescence, or equi factor neutralization, however, showed that antibody is widespread in the horse population (46, 71, 151, 152, 162, 180) . The intestinal tract is probably the major source of antigenic stimulation (30, 131, 160, 163 (163, 164) .
In foals, maternal antibody from colostrum declines to its lowest levels by about 8 weeks of age, after which time antibody is actively produced by the foal. Foals with low levels of maternal antibody detected by ELISA are particularly susceptible to naturally induced R. equi pneumonia (4, 71) , emphasizing the importance of antibody in enhanced uptake and killing by macrophages and neutrophils (69, 70, 103, 170) . The clinical severity of R. equi pneumonia may be related to the amount of specific antibody present, since foals with higher amounts show milder disease (71) .
Recently, the immunoprophylactic capacity of specific immune plasma in foals with experimentally induced R. equi pneumonia has been elegantly established (101) , supporting earlier suggestions that plasma or serum might be used to treat R. equi infections (15, 68, 97) . The clinical course of the disease in passively immunized foals was dramatically less severe than that in foals treated with plasma from nonimmunized donors (101) . Plasma donor horses for this experiment were immunized with live R. equi. Immunized foals had significantly higher ELISA values than control foals administered plasma from nonimmunized horses. Nevertheless, in this passive immunization study one foal with very low ELISA values did not develop clinical disease, whereas a second with high ELISA values died (101) . Direct evidence for a protective function capacity of R. equi antibody detected by ELISA is lacking. Indeed, levels of ELISA antibody correlate poorly with measures of opsonizing activity such as bactericidal and chemiluminescence assays (102) . Part of the protective effect of immune plasma may therefore result from nonspecific factors in plasma, including lymphokines and interferons (101) . Trials are now being conducted in the field to confirm the value of passive immunization in the control of R. equi pneumonia in foals. However, further work is required to define the basis of the protection observed experimentally.
The nature of the antigens that give rise to the opsonizing and possible protective effect of specific antiserum to R. equi is not established. Antigens used in ELISA procedures have been largely derived from the bacterial surface or from culture supernatants and therefore would likely include both capsular polysaccharide and the exoenzyme (equi factors) antigens in major amounts (46, 71, 162, 163) . Although antibodies to equi factors might be involved in protective immunity, it is more likely that protective antigens are bacterial surface components. Immunoblotting procedures with sera from healthy as well as pneumonic foals, however, showed greater antibody responses to supernatant products than to whole cells of R. equi (29) .
Celular Immunity in Horses
Cell-mediated mechanisms are thought to be the major means of immunity to R. equi and other intracellular pathogens such as Mycobacterium tuberculosis (87, 109) . Protection against such intracellular pathogens depends on subtle and complex coordination of the cell-mediated immune response, which is poorly understood. A primary event in intracellular killing is activation of macrophages by gamma interferon, a lymphokine secreted primarily by CD4+ lymphocytes (87) . Some strains of mycobacteria, however, are resistant to killing by macrophages stimulated by gamma interferon, suggesting that other cells may be involved, for example, CD8+ cytotoxic cells or macrophages activated by other cytokines such as tumor necrosis factor (87). Thus, VOL. 4, 1991 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from while gamma interferon plays a central role in protecting animals against intracellular pathogens by activating macrophages, an apparently coordinated but poorly understood interplay with other T cells is also needed (87) .
The molecular mechanisms that culminate in the generation of antigen-stimulated gamma interferon are complex and also poorly understood. Theoretically, any interference with one or more of the key steps leading to macrophage activation (accessory cell function, interleukin 1 and 2 secretion, interleukin 2 receptor suppression) could lead to a failure of gamma interferon production and consequently impaired immunity to an intracellular pathogen. There is no evidence that R. equi specifically affects any of these steps in foals. In human patients with certain severe manifestations of leishmaniasis, leprosy, and tuberculosis, in vitro defects in antigen-induced gamma interferon production are limited to failure to respond to the infecting pathogen alone (109) . This restricted and reversible antigen-specific defect correlates with a lack of generalized susceptibility to opportunist pathogens in such patients. There is no evidence that such an event occurs in foals, though it seems likely that components of R. equi may induce immunosuppression of some type, as, for example, does the mycobacterial cell wall constituent, arabinomannan (65) . Support for immunosuppressive activity of R. equi components comes from a study in which injection of mice with a water-soluble extract of R. equi suppressed production of reaginic antibodies against a hapten carrier (55) .
Less is known about the role and importance of cellmediated immunity to R. equi than humoral immunity. Because of the intracellular nature of the organism, cellmediated immunity is assumed to be of major importance in R. equi infections (45, 131) . Delayed-type hypersensitivity skin reactions have been demonstrated in apparently healthy or experimentally infected horses (45, 180, 182) and indicate widespread exposure to R. equi. Such hypersensitivity develops with age but does not reflect the extent of environmental contamination (180) .
The best descriptions of the important interactions of cell-mediated immunity with humoral immunity come from in vitro studies of macrophage killing of R. equi (69) . Alveolar macrophages from foals that had been experimentally exposed to R. equi phagocytized and killed both nonopsonized and opsonized R. equi more efficiently than alveolar macrophages from nonexposed control foals. The activity of macrophages from exposed foals was similar to that of macrophages from adult horses, although the rate of killing of opsonized R. equi was slightly less in foals. In all alveolar macrophages tested, opsonization of R. equi markedly increased phagosome-lysosome fusion compared with nonopsonized bacteria. Supernatants from foal lymphocyte cultures stimulated with R. equi antigens significantly enhanced killing of R. equi by alveolar macrophages isolated from both exposed and nonexposed foals. The combination of humoral (opsonized bacteria) and cell-mediated (T-cell-activated macrophages) immunity resulted in complete killing by incubated macrophages in vitro (69) . These studies underline the importance of both humoral and cellular immunity in protection of horses against R. equi pneumonia and reinforce the conclusion from reports of R. equi pneumonia in patients with AIDS that cell-mediated immunity is of major importance in resistance to infection. Understanding of cellmediated aspects of immunity of foals to R. equi is clearly rudimentary.
Although not well documented, anecdotal evidence suggests that individual mares may consistently produce foals that are particularly susceptible to infection (180, 182) . Such susceptibility might be explained by low colostral antibody levels, the functional immaturity of neutrophils in certain foals (99) , or a genetically controlled predisposition to infection. Reports of horse breed predisposition to infection are conflicting, with suggestions that Arabians (49) or Standardbreds (199) may be at increased risk. Resistance in mice to intracellular pathogens is genetically determined, occurring at the level of the macrophage independently of T-cell function (21) . The single gene or gene complex determining resistance to intracellular pathogens such as M. lepraemurium, Salmonella typhimurium, Leishmania donovani, and M. bovis (BCG) is the Bcg gene (or complex) on chromosome 1 (21) . Other species such as cattle appear to have innate macrophage-based resistance to other facultative intracellular pathogens (134) .
Immunity to Infection in Humans Impairment of cell-mediated immune mechanisms predisposes human patients to R. equi infections. Immunosuppressive drugs (cyclosporin A, corticosteroids, and antimetabolites) suppress mitogen-induced gamma interferon production by CD4+ cells in many renal and bone marrow transplant recipients and in patients treated for lymphatic leukemias (Table 1) . Therefore, these patients are susceptible to an array of opportunistic infections caused by intracellular pathogens (109) . In adult AIDS patients, the characteristic destruction of CD4+ cells by the virus impairs cell-mediated immune mechanisms and predisposes to infection with a variety of intracellular organisms that require an intact T-cell-macrophage system (40) . These infections may represent reactivated latent infections (toxoplasmosis, tuberculosis, herpes simplex virus, or cytomegalovirus infections), be caused by agents such as Pneumocystis carinii which do not cause disease in healthy hosts, or be acquired opportunists such as M. avium-M. intracellulare complex, Salmonella enteritidis, Cryptococcus neoformans, or Cryptosporidium parvum (14) , or, rarely, R. equi. M. avium-M. intracellulare complex infection is a late occurrence in AIDS patients causing widely disseminated systemic disease and is observed in 25 to 30% of adult AIDS patients at the time of death (27, 194) . The relative infrequency of infections with other environmental opportunistic intracellular pathogens such as N. asteroides or Listeria monocytogenes (or even R. equi) compared with the frequency of M. avium-M. intracellulare complex infection (94) suggests that the AIDS virus has a special preference for T cells involved in immunity against mycobacterial cells (37) .
Immunotherapy in Horses
Field studies by Magnusson in 1923 and 1924 failed to show the value of vaccination with "killed broth cultures" of R. equi (97) . Vaccination of foals with a Formalin-killed R.
equi bacterin did not protect them against a heavy intratracheal challenge (129) . The excellent protection against aerosol challenge which followed oral immunization of young foals (immunized on four occasions over 5 weeks with a nonattenuated clinical isolate of R. equi [30] ) supports the idea that intestinal exposure of foals to R. equi results in natural vaccination. The basis of this protection was not established, although others have shown that specific IgG levels rise in foals after oral administration of R. equi (162, 166) .
Effective immunization against intracellular bacterial pathogens such as mycobacteria requires the use of live organisms rather than killed vaccines to promote cellular immunity. The reasons are unclear but may relate to a requirement for antigen persistence, the activation of different pathways within phagocytic cells, or, least likely, the secretion of specific protective antigens by live organisms (32) . Although the relative importance of each arm (cell mediated, humoral) of the immune system in resistance to R. equi is unknown, it seems likely that vaccination with live organisms, which promotes cell-mediated immunity, will be required to protect foals fully against R. equi pneumonia. The value of both opsonizing antibody in promoting uptake and killing by macrophages and passive immunization in protecting against pneumonia has been established and supports continued attempts to define the antigens required to promote protective antibodies.
Whereas the role of a protective antigen is well established in antibody-mediated immunity, it is highly speculative in cell-mediated immunity, in which protection may involve a complex balance requiring recognition of many antigens as well as a variety of T-cell subsets (92, 193) . Indeed, despite considerable efforts, immunodominant determinants of M. tuberculosis and M. leprae, including those which induce expansion of T cells with selective function, have not yet been isolated and characterized (92, 143, 193) .
Active immunization is not an option in human patients with AIDS, and the value of passive immunization with hyperimmune anti-R. equi serum in treating foals has not been fully determined. Another approach to immunotherapy might involve lymphokine therapy. Trials in humans indicate that gamma interferon activates human macrophages in vivo and induces other immunoregulatory activities, including natural killer cell number and cytotoxicity, lymphocyte proliferation and monocyte Fc receptor expression (109) . These trials do not suggest that gamma interferon activates macrophages against all intracellular pathogens, but do support the value of further work to define those diseases in which such lymphokine therapy might be effective (109) . R. equi pneumonia of foals or other experimental animals might therefore be a useful model to determine the value of immunotherapy in AIDS patients with R. equi infections.
LABORATORY DIAGNOSIS Isolation and Identification of the Organism
Isolation and colonial morphology. R. equi grows readily when incubated aerobically at 37°C on nonselective media routinely used in clinical microbiology laboratories. At 24 h of incubation, colonies are 1 to 2 mm in diameter and are not distinctive. By 48 h of incubation on nonselective media such as Trypticase soy blood agar, they have developed their characteristic appearance (Fig. 2) : irregularly round, smooth, semitransparent, glistening, coalescing, mucoid, teardrop colonies with entire edges. The colonies vary in size from 2 to 4 mm, although coalesced colonies may appear larger. The organism does not grow on most types of MacConkey agar. Rare isolates of R. equi may grow poorly at 37°C (108) .
Colony variation is present in fresh cultures. The classical viscous-mucoid coalescing colony is usually the predominant type present, but less mucoid forms may also be seen. A small proportion of small, 1 mm or less, nonmucoid colonies are also present (Fig. 2) . In addition to the colony variation within a strain, four stable colony types of R. equi have been described (classical mucoid, less mucoid, disso- Pigment production is rarely marked in cultures <4 days old (6) and may surprise those expecting all rhodococci (red-pigmented cocci) to show obviously pink or red colonial pigmentation immediately on isolation. After 4 to 7 days on nonselective medium, such as Trypticase soy blood agar, colonies may develop a delicate shade of salmon pink, although they may be nonpigmented or appear slightly yellow (6) . Perhaps the best description of the typical colony pigment on blood agar is as light fawn colored. Cultures kept on slopes for prolonged periods without subculture commonly become rough, dry, and orange-red but revert to classical colonies on subculture (86, 181) . The macroscopic colony morphology of the type culture, ATCC 6939 (96) , is smaller than usual, smooth, and dry (rather than mucoid) and appears more pigmented than typical R. equi.
Microscopic morphology and staining properties. R. equi is a gram-positive pleomorphic coccobacillus, varying from distinctly coccoid to bacillary depending on growth conditions. It is usually coccoid, both on solid media and in purulent material from patients, but in liquid media, particularly in young cultures, it forms long rods or short filaments which may show rudimentary branching.
The occasional reports that R. equi is acid fast in the Ziehl-Neelsen stain appear to depend on staining technique, the older age of the cultures, and the growth medium (6, 82, 177 (113) . All isolates FIG. 3 . Demonstration of the production of equi factors, which is a consistent and useful identifying characteristic of R. equi. R. equi has been streaked vertically on the left-and right-hand sides of the plates. The upper horizontal streak culture is Corynebacterium pseudotuberculosis and the lower is a beta-toxin-producing S. aureus. Left-hand side is a 48-h growth of the isolates; right-hand side is a 24-h growth.
tested were positive for leucine arylamidase, acid phosphatase, and phosphamidase; >90% were positive for valine amylamidase, esterase lipase, and alpha-glucosidase.
Other identifying characteristics. The organism grows over a wide range of temperature, from 10 to 40°C. Although disputed, the optimal temperature of growth appears to be 30°C, but growth rate is only marginally less at 37°C (78) . Cultures grow as well at room temperature as at 37°C (97) . R. equi is an obligate aerobe with simple growth requirements (61) . It can utilize carbon from a wide variety of sole carbon sources (63) , including acetic, pyruvic, butyric, and propionic acids (190) and nitrogen from ammonium sulfate or potassium nitrate (123) . The organism is nonmotile and nonflagellated and may produce small numbers of pili (192) .
Organisms grow readily in nonselective broth media, generally producing moderate turbidity, sometimes with a slight salmon-pink sediment after 48 h (86). Some strains may produce a thin pellicle which is readily disrupted (6, 174) . Antimicrobial drug susceptibility, discussed below, is consistent and might be a useful adjunct in identification. The electrophoresis pattern of whole-cell preparations in polyacrylamide gels has been described before (28) . Further characteristics of R. equi, which cannot be readily determined in a routine clinical microbiology laboratory but are used in taxonomic classification, have been discussed previously (see section, Taxonomic Status).
Capsular serotypes. R. equi possesses a distinct, antigenically variable, lamellar polysaccharide capsule (185) , which has provided the basis of a capsular serotyping system (118, 124) . At least 27 different capsular serotypes have been identified (118) , of which Prescott capsular serotype 1 (or its equivalent in other typing schemes) is the most common worldwide (88, 110, 118, 124) . No relationship between serotype and virulence is apparent.
Diagnostic Procedures
Isolation of R. equi from the infection site is the best method of diagnosing infection. In humans with pneumonic disease, sputum is often but not always a useful specimen (60, 98) . Diagnosis is more reliably made by bronchial brushings, percutaneous thoracic aspiration, or, more drastically, open lung biopsy during lobectomy (24, 66, 148 (127) . An agar gel immunoprecipitation test for antibody to equi factors was also shown to identify foals with R. equi pneumonia, although a small proportion of apparently healthy foals as also positive in the test (117) . Using more sensitive synergistic-hemolysis inhibition and immunoprecipitation assays than described previously, Skalka demonstrated the widespread nature of subclinical infection or exposure to R. equi in foals (151, 152) .
In general, ELISA has been used to distinguish infected from healthy foals (162) . In one study, a Tween 20 extract from the type strain, ATCC 6939, gave the broadest crossreactivity of the serotypes tested (162) . The mean values of anti-R. equi IgG antibody in foals known or suspected to be ill with R. equi pneumonia were strikingly higher than in normal foals in the limited number of animals tested, but there were no differences in mean values of anti-R. equi IgM or IgA antibodies (162, 163) . This ELISA was more sensitive than agar gel diffusion or indirect haemagglutination tests (162) . In two unrelated studies, using different antigens, no correlation was found between ELISA antibody levels and clinical disease (46, 71) . The (161) .
TREATMENT AND CONTROL Antimicrobial Susceptibility The usual antimicrobial drug susceptibility of R. equi is shown in Table 4 . The organism is particularly susceptible to erythromycin and clindamycin; the aminoglycosides amikacin, gentamicin, neomycin, and tobramycin; rifampin; and vancomycin. It is only moderately susceptible to penicillin G, ampicillin, and tetracyclines and is usually moderately susceptible or resistant to first-and second-generation cephalosporins.
Successful treatment of R. equi infections depends on the use of lipophilic antimicrobial drugs that can penetrate the macrophages or neutrophils in which the organisms survive (74, 75, 132) . The standard treatment in pneumonic foals is oral administration of a combination of erythromycin estolate and rifampin (75) . Not only are these drugs highly effective in vitro, they also penetrate macrophages well and have been shown to have additive and often synergistic activity in vitro (130) . Use of this combination has considerably reduced foal mortality due to R. equi infection (74, 159) . These drugs have also been used alone or in combination, usually with good clinical response, in many human infections (73, 85, 90, 121, 146, 147) . Although the combina- tion of gentamicin with penicillin gave additive and sometimes synergistic activity in vitro (130) , in one study, use of this combination to treat foals with R. equi pneumonia was invariably associated with their death (74) , possibly because penetration of macrophages or neutrophils by these drugs is so poor. Others, however, have used this combination in foals with greater success (155) . Successful treatment of R. equi pneumonia in foals depends not only on the choice of lipophilic antimicrobial drugs but also on prolonged treatment, usually until the animals appear radiographically and hematologically normal (74, 159) . Return of serum fibrinogen concentrations to normal has been used as an indicator of successful treatment (74) . Duration of therapy is often fromclinically (51, 146) . Penicillin G administered intravenously in high doses has been used successfully to treat foals with R. equi pneumonia (58) but cannot be recommended because of the hydrophilic nature of penicillin, the organism's relative resistance, and the difficulty of administering drug by this route. Some human infections have not responded to benzyl penicillin (24) , although response to ampicillin or amoxicillin has been described (98, 148) . Resistance to beta-lactam antibiotics has also developed during therapy in human patients (146, 178) . For these reasons, beta-lactam drugs should probably be avoided or administered only with other drugs. In vitro, the combination of penicillin and erythromycin showed synergistic activity (130) . The combination of gentamicin with erythromycin or rifampin in vitro gave antagonistic activity compared with either drug alone (130) and should probably be avoided in treatment.
Besides the use of antimicrobial drugs, the approach used in treatment of human infection involves drainage of suppurative lesions, surgical resection of granulomatous tissue, and control of predisposing factors such as decreasing the dose of concurrent immunosuppressive drugs or control of underlying malignancies. More information is needed on the value of gamma interferon (see subsection, "Immunotherapy in Horses") because its use has been contraindicated in human infections involving certain intracellular parasites.
CONCLUSIONS
Much has been learned in the last decade about R. equi infections in foals that can be applied to the diagnosis and treatment of infection in humans. Important questions about the disease in foals remain to be resolved to improve control of infection in both horses and humans. The development of a suitable mouse model for infection, for example, using mice with genetically defined immunological defects, would reduce the expense and other difficulties of using foals as an experimental animal. Such a mouse model could be used to define the antigen(s) of importance in humoral immunity and the value of antibody to them in the prevention and treatment of infection, the antigens of importance in and the basis of cellular immunity to infection, the value of gamma interferon or other lymphokines in the treatment of infection, and the optimal antimicrobial treatment regimen. Also, such a model could be used to compare the virulence of different strains, including the nonpathogenic ATCC 6939, and to relate virulence differences to cell wall components. This information might be useful in the development of effective vaccines. A model is needed to screen candidate live vaccines for potential use in foals. Availability of a suitable model would also allow investigation of the role of T-cell subsets in the pathogenesis of infection.
